Interleukin-1 receptors: Cloning studies and role in central nervous system disorders

Brain Research Reviews

Volumn 26, Issue 2-3, 1998, Pages 306-319

  Loddick, Sarah A ^a   Liu, Changlu ^a   Takao, Toshihiro ^b   Hashimoto, Kozo ^b   De Souza, Errol B ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Brain; Interleukin receptors; Localization; Neurodegenaration; Transduction

Indexed keywords

INTERLEUKIN 1 RECEPTOR;

ANIMAL TISSUE; BRAIN DISEASE; CONFERENCE PAPER; MOLECULAR CLONING; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CASPASE 1; CENTRAL NERVOUS SYSTEM DISEASES; CLONING, MOLECULAR; CYSTEINE ENDOPEPTIDASES; HUMANS; NERVE DEGENERATION; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 0032079085     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00037-4     Document Type: Conference Paper

References (186)

1. Alcami A., Smith G.L. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell. 71:1992;153-167.
2. S.M. Allan, C.B. Lawrence, N.J. Rothwell, Mechanism of action of interleukin-1 (IL-1) in excitotoxic brain damage in the rat, Soc. Neurosci. Abstr. 21 (1995) 37.14.
3. Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thornberry N.A., Wong W.W., Yuan J. Human ICE/CED-3 protease nomeclature. Cell. 87:1996;171.
4. Andersson P.B., Perry V.H., Gordon S. Intracerebral injection of proinflammatory cytokines or leucocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the CNS. J. Exp. Med. 176:1992;255-259.
5. D.M. Araujo, Contrasting effects of specific lymphokines on the survival of hippocampal neurons in culture. In: E.M. Meyer (Ed.), Treatment of Dementias, New York, 1992, pp. 113-122.
6. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
7. Beekhuizen H., Van Furth R. Monocyte adherence to human vascular endothelium. J. Leukocyte Biol. 54:1993;363-378.
8. E.N. Benveniste, Cytokines: influence on glial cell gene expression and function. In: J.E. Blalock (Ed.), Neuroimmunoendocrinology, 52, Basel, 1992, pp. 106-153.
9. Bergers G., Reikerstorfer A., Braselmann S., Graninger P., Busslinger M. Alternative promoter usage of Fos-resposive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13:1994;1176-1188.
10. Berkenbosch F., Van Oers J., Delrey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 238:1987;237-239.
11. Betz A.L., Yang G.-Y., Davidson B.L. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. 15:1995;547-551.
12. Bhat R.V., DiRocco R., Marcy V.R., Flood D.G., Zhu Y., Dobrzanski P., Siman R., Scott R., Contreras P.C., Miller M. Increased expression of IL-1beta converting enzyme in hippocampus after ischemia: selective localization in microglia. J. Neurosci. 16:1996;4146-4154.
13. Blatteis C.M. Neural mechanisms in the pyrogenic and acute-phase responses to interleukin-1. Int. J. Neurosci. 38:1988;223-232.
14. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
15. Bomsztyk K., Sims J.E., Stanton T.H., Slack J., McMahan C.J., Valentine M.A., Dower S.K. Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Proc. Natl. Acad. Sci. USA. 86:1989;8034-8038.
16. Boulant J.A., Demieville H.N. Responses of thermosensitive preoptic and septal neurons to hippocampal and brain stem stimulation. J. Neurosci. 12:1977;1101-1114.
17. Breder C., Dinarello C.A., Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 240:1988;321-324.
18. Breder C.D., Saper C.B. Interleukin-1β-like immunoreactive innervation in the human central nervous system. Soc. Neurosci. Abstr. 15:1989;715.
19. Bristulf J., Gatti S., Malinowsky D., Bjork L., Sundgren A.K., Bartfai T. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA. Eur. Cytokine. Netw. 5:1994;319-330.
20. Busbridge N.J., Dascombe M.J., Tilders F.J.H., Van Oers J.W.A.M., Linton E.A., Rothwell N.J. Central activation of thermogenesis and fever by IL-1beta and IL-1alpha involves different mechanisms. Biochem. Biophys. Res. Commun. 162:1989;591-596.
21. Buttini M., Sauter A., Boddeke H.W.G.M. Induction of interleukin-1 beta messenger RNA after focal cerebral ischaemia in the rat. Mol. Brain Res. 23:1994;126-134.
22. Cao Z., William J.H., Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science. 271:1996;1128-1131.
23. Cerretti D.P., Kozlosky C.J., Mosley B., Nelson N., Ness K.V., Greenstreet T.A., March C.J., Kronheim S.R., Druck T., Cannizzaro L.A., Huebner K., Black R.A. Molecular cloning of the interleukin-1β converting enzyme. Science. 256:1992;97-100.
24. R.M.E.E. Chalmers-Redman, A.D. Fraser, W.Y.H. Ju, J. Wadia, N.A. Tatton, W.G. Tatton, Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischemia. In: A.R. Green and A.J. Cross (Eds.), Neuroprotective agents and cerebral ischemia, International Review of Neurobiology, 40, London, 1997, pp. 1-25.
25. Chen H., Chopp M., Bodzin G. Neutropenia reduces the volume of cerebral infarction after transient middle cerebral artery occlusion in the rat. Neurosci. Res. Commun. 11:1992;93-99.
26. Chopp M., Chan P.H., Hsu C.Y., Cheung M.E., Jacobs T.P. DNA damage and repair in central nervous system injury. Stroke. 27:1996;363-369.
27. Clarke R.K., Lee E.V., Fish C.J., White R.F., Price W.J., Jonak Z.L., Feuerstein G.Z., Barone F.C. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res. Bull. 31:1993;565-572.
28. Colotta F., Re F., Muzio M., Bertini B., Polentarutti N., Sironi M., Giri J.G., Dower S.K., Sims J.E., Mantovani A. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 261:1993;472-475.
29. Cunningham E., Wada E., Carter D., Tracey D., Battey J., De Souza E. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. J. Neuroscience. 12:1992;1101-1114.
30. Cunningham E.T. Jr., Wada E., Carter D.B., Tracey D.E., Battey J.F., De Souza E.B. Localization of interleukin-1 receptor messenger RNA in murine hippocampus. Endocrinology. 128:1991;2666-2668.
31. Dascombe M.J., Hardwick A., Lefeure R.A., Rothwell N.J. Impaired effects of interleukin-1β on fever and thermogenesis in genetically obese rats. Int. J. Obesity. 13:1989;367-373.
32. C. Davies, J. Hunt, S.A. Loddick, P. Stroemer, N.J. Rothwell, The progression and topographical distribution of interleukin-1β expression after permanent middle cerebral artery occlusion in the rat, submitted.
33. DeMarco D., Kunkel S.L., Strieter R.M., Basha M., Zurier R.B. Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells. Biochem. Biophys. Res. Commun. 174:1991;411-416.
34. N. Di Julio, A. Urrutia, D.L. Gruol, Interleukin-1β increases intracellular calcium and alters the electrophysiology of cultured cerebellar purkinje neurons, Soc. Neurosci. Abstr. 17 (1991) 475.4.
35. Dinarello C.A. Biology of interleukin-1. FASEB J. 2:1988;108-115.
36. Dinarello C.A. Interleukin-1 and interleukin-1 antagonist. Blood. 77:1991;1627-1652.
37. Duan H., Chinnaiyan A.M., Hudson P.L., Wing J.P., He W.W., Dixit V.M. ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271:1996;1621-1625.
38. Duan H., Orth K., Chinnaiyan A.M., Poirier G.G., Froelich C.J., He W.W., Dixit V.M. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271:1996;16720-16724.
39. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:1986;245-254.
40. Enari M., Hug H., Nagata S. Involvement of ICE and ICE-like protease in Fas-mediated apoptosis. Nature. 375:1995;78-81.
41. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361:1995;681-698.
42. Fagan A.M., Gage F.H. Cholinergic sprouting in the hippocampus: a proposed role for IL-1. Exp. Neurol. 110:1990;105-120.
43. Farooqui A.A., Horrocks L.A. Excitatory amino acid receptors, neuronal membrane phospholipid metabolism and neurological disorders. Brain Res. Rev. 16:1992;171-191.
44. Farrar W.L., Hill J.M., Harel-Bellan A., Vinocour M. The immune logical brain. Immunol. Rev. 100:1987;361-368.
45. Farrar W.L., Kilian P.C., Ruff M.R., Hill J.M., Pert C.B. Visualisation and characterisation of interleukin-1 receptors in the brain. J. Immunol. 139:1987;459-463.
46. Faucheu C., Diu A., Chan A.W., Blanchet A.M., Miossec C., Herve F., Collard-Dutilleul V., Gu Y., Aldape R.A., Lippke J.A., Rocher C., Su M.S.-S., Livingstone D.J., Herland T., Lalanne J.-L. A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J. 14:1995;1914-1922.
47. Fenandes-Alnemri T., Litwack G., Alnemri E.S. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res. 55:1995;2737-2742.
48. Fernandes-Alnemri T., Armstrong R., Krebs J., Srinivasula S.M., Wang L., Bullrich F., Fritz L.C., Trapani J.A., Tomaselli K.J., Litwack G., Alnemri E.S. In vito activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA. 93:1996;7464-7469.
49. Fernandes-Alnemri T., Takahashi A., Armstrong R., Krebs J., Fritz L., Tomaselli K.J., Wang L., Yu Z., Croce C.M., Salveson G., Earnshaw W.C., Litwack G., Alnmeri E.S. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55:1995;6045-6052.
50. Fontana A., Kriestensen F., Dubs R., Gemsa D., Weber E. Production of prostaglandin E and interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J. Immunol. 129:1982;2413-2419.
51. Fontana A., Weber E., Dayer J.M. Synthesis of interleukin-1/endogenous pyrogen in the brain of endotoxin treated mice: A step in fever induction. J. Immunol. 133:1984;1696-1698.
52. Gagliardini V., Fernandez P., Lee R.K., Drexler H.C., Rotello R.J., Fishman M.C., Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science. 263:1994;826-828.
53. Garcia J.H., Kamijyo Y. Cerebral infarction. Evolution of histopathological changes after occlusion of a middle cerebral occlusion in primates. J. Neuropath. Exp. Neurol. 33:1974;408-421.
54. Garcia J.H., Liu K.-F., Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147:1995;1477-1486.
55. Gery I., Gershon R.K., Waksman B.H. Potentiation of the T-lymphocyte response to mitogens I. The responding cell. J. Exp. Med. 136:1972;128-142.
56. Giulian D., Baker T.J., Shih L.N., Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164:1986;594-604.
57. Giulian D., Lachman L.B. Interleukin-1 stimulates astroglial proliferation after brain injury. Science. 228:1985;497-499.
58. Giulian D., Tapscott M. Immunoregulation of cells within the central nervous system. Brain Behav. Immun. 2:1988;352-358.
59. Giulian D., Vaca K., Corpuz M. Brain glia release factors with opposing actions on neuronal survival. J. Neurosci. 13:1993;29-37.
60. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularisation. J. Neurosci. 8:1988;2485-2490.
61. Giulian D., Young D.G., Woodward J., Brown D.C., Lachman L.B. Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8:1988;709-714.
62. Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G. Molecular cloning and characterisation of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270:1995;13757-13765.
63. Griffin W.S.T., Stainley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain Interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
64. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Ayata G., Yuan J., Moskowitz M.A. Effects of transient focal cerebral ischemia in interleukin 1-beta converting enzyme (ICE) mutant mice. Circulation Suppl. 94:1996;2283.
65. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., Moskowitz M.A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA. 94:1997;2007-2012.
66. Hart R.P., Liu C., Shadiack A.M., McCormack R.J., Jonakait G.M. An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia. J. Neuroimmunol. 44:1993;49-56.
67. Henkart P.A. ICE family proteases: mediators of all apoptotic cell death? Immunity. 4:1996;195-201.
68. Hetier E., Ayala J., Denefle A., Bousseau A., Rouget P., Mallat M., Prochiantz A. Brain macrophages synthesize interleukin-1 and interleukin-1 mRNA in vitro. J. Neurosci. Res. 21:1988;391-397.
69. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164:1993;229-232.
70. Hopkins S.J., Rothwell S.J. Cytokines and the nervous system I: expression and recognition. TINS. 18:1995;83-88.
71. Hori T., Osaka T., Kiyohara T., Shibata M., Nakashima T. Hippocampal input to preoptic thermosensitive neurons in the rat. Neurosci. Lett. 32:1982;155-158.
72. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischaemia in mice deficient in neuronal nitric oxide. Science. 265:1994;1883-1885.
73. Ianotti F., Kida S., Weller R., Buhagier G., Hillhouse E. Interleukin-1β in focal cerebral ischaemia in rats. J. Cereb. Blood Flow Metab. 13:1993;s125.
74. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12:1991;118-134.
75. Kamens J., Oaskind M., Hugunin M., Talanian R.V., Allen H., Banach D., Bump N., Hackett M., Johnston C.G., Li P., Mankovich J.A., Terranova M., Ghayur T. Identification and characterisation of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J. Biol. Chem. 270:1995;15250-15256.
76. Kampschmidt R.F. The numerous postulated biological manifestations of interleukin-1. J. Leukocyte Biol. 36:1984;341-355.
77. Kato H., Kogure K., Araki T., Yasuto I. Astroglial and microglial reactions in the gerbil hippocampus with induced ischemic tolerance. Brain Res. 664:1994;69-76.
78. Katsuura G., Gottschall P.E., Arimura A. Identification of a high affinity receptor for interleukin-1 beta in rat brain. Biochem. Biophys. Res. Commun. 156:1988;61-67.
79. Keane K.M., Giegel D.A., Lipinski W.J., Calahan M.J., Shivers B.D. Cloning, tissue expression and regulation of rat interleukin-1β converting enzyme. Cytokine. 7:1995;105-110.
80. Keller-Wood M.E., Dallman M.F. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5:1984;1-24.
81. Kilbourn R.G., Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J. Natl. Cancer Inst. 82:1990;772-776.
82. Kostura M.J., Tocci M.J., Limjuco G., Chin J., Cameron P., Hillman A.G., Chartrain N.A., Schmidt J.A. Identification of a monocyte specific pre-interleukin-1β convertase activity. Proc. Natl. Acad. Sci. USA. 86:1989;5227-5231.
83. Krueger J.M., Walter J., Dinarello C.A., Wolff S.M., Chedid L. Sleep promoting effects of endogenous pyrogen (interleukin-1). Am. J. Physiol. 246:1984;R994-R999.
84. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J., Su M.S.S., Flavell R.A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 267:1995;2000-2003.
85. Kumar S., Kinoshita M., Noda M., Copeland N.G., Jenkins N.A. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta converting enzyme. Genes Devel. 8:1994;1613-1626.
86. Lachman L.B., Brown D.C., Dinarello C.A. Growth promoting effects of IL-1 and TNF for human astrocyte cell line. J. Immunol. 138:1987;2913-2916.
87. Lawrence C.B., Rothwell N.J. Interleukin-1 receptor antagonist inhibits NMDA and AMPA receptor induced brain damage in the rat. Br. J. Pharmacol. 112:1994;484P.
88. Lechan R.M., Toni R., Clark B.D., Shaw A.R., Dinarello C.A., Reichlin S. Immunoreactive interleukin-1β localizaion in the rat forebrain. Brain Res. 514:1990;135-140.
89. Letsou A., Alexander S., Orth K., Wasserman S.A. Genetic and molecular characterization of tube, a Drosophila gene maternally required for embryonic dorsoventral polarity. Proc. Natl. Acad. Sci. USA. 88:1991;810-814.
90. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., McDowell J., Paskind M., Rodman L., Salfeld J., Towne E., Tracey D., Wardwell S., Wei F.-Y., Wong W., Kamen R., Seshadri T. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell. 80:1995;401-411.
91. Lin M.T., Kao T.Y., Jin Y.T., Chen C.F. Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing ischemia in rats. Brain Res. Bull. 37:1995;595-598.
92. Lippke J.A., Gu Y., Sarnecki C., Caron P.R., Su M.S. Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271:1996;1825-1828.
93. Lipton S.A., Roenberg P.A. Excitatory amino acids as a final common pathway for neurological disorders. New Engl. J. Med. 330:1994;613-622.
94. Liu C., Chalmers D., Maki R., De Souza E.B. Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies. J. Neuroimmunol. 66:1996;41-48.
95. Liu C., Ganea D., Hart R.P. A soluble IL-1 receptor is expressed in cultured rat sympathetic ganglia from the type I IL-1 receptor gene. Soc. Neurosci. Abst. 19:1993;95.
96. Liu C., Hart R.P., Liu X.-J., Clevenger W., Maki R., De Souza E.B. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA. J. Biol. Chem. 271:1996;20965-20972.
97. Liu T., McDonnell P.C., Young P.R., White R.F., Siren A.L., Hallenbeck J.M., Barone F.C., Feurestein G.Z. Interleukin-1 beta mRNA expression in ischaemic rat cortex. Stroke. 24:1993;1746-1750.
98. Loddick S.A., MacKenzie A., Rothwell N.J. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. NeuroReport. 7:1996;1465-1468.
99. Loddick S.A., Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16:1996;932-940.
100. Loddick S.A., Wong M.-L., Bongiorno P.B., Gold P.W., Licinio J., Rothwell N.J. Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem. Biophys. Res. Commun. 234:1997;211-215.
101. Los M., Van de Craen M., Penning L.C., Schenk H., Westendorp M., Baeuerle P.A., Droge W., Krammer P.H., Fiers W., Schulze-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/APo-1-mediated apoptosis. Nature. 375:1995;81-83.
102. Lovenberg T.W., Crowe P.D., Liu C., Chalmers D.T., Liu X.J., Liaw C., Clevenger W., Oltersdorf T., De Souza E.B., Maki R.A. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL-1R-rp2). J. Neuroimmunol. 70:1996;113-122.
103. Lue F.A., Bail M., Jephthaah-Ochola J., Gorczynski R., Moldofsky H. Sleep and interleukin-1-like activity in cat cerebrospinal fluid. Int. J. Neurosci. 42:1988;179-183.
104. Luheshi G., Hopkins S.J., LeFeuvre R.A., Dascombe M.J., Ghiara P., Rothwell N.J. Importance of brain IL-1 type II receptors in fever and thermogenesis in the rat. Am. J. Physiol. 265:1993;E585-E591.
105. Martin D., Chinookoswong N., Miller G. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischaemia. Exp. Neurol. 130:1995;362-367.
106. Mathias S., Younes A., Kan C.C., Orlow I., Joseeph C., Kolesnick R.N. Activation of the sphingomyelin signal pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science. 359:1993;519-522.
107. McCarthy D.O., Kluger M.J., Vander A.J. Suppression of food intake during infection: is interleukin-1 involved? Am. J. Clin. Nutr. 42:1985;181-184.
108. McMahan C.J., Slack J.L., Mosley B., Cosman D., Lupton S.D., Brunton L.L., Grubin C.E., Wignall J.M., Jenkins N.A., Brannan C.I., Copeland N.G., Huebner K., Croce C.M., Cannizzarro L.A., Benjamin D., Dower S.K., Spriggs M.K., Sims J.E. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:1991;2821-2832.
109. Meldrum B.S. The role of glutamate in epilepsy and other CNS disorders. Neurol. 44:1993;S14-23.
110. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. TIPS. 11:1990;379-386.
111. Merrill J.E., Chen I.S. HIV-1, macrophages, glial cells and cytokines in AIDS nervous system disease. FASEB J. 5:1991;2391-2397.
112. Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., Satoh M. Induction of interleukin-1 mRNA in rat brain after transient forebrain ischaemia. J. Neurochem. 58:1992;390-392.
113. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., Satoh M. Convulsants induce interleukin-1 messenger RNA in rat brain. Biochem. Biophys. Res. Commun. 171:1990;832-837.
114. M. Minami, K. Yabuuchi, S. Katsumata, Y. Tomozawa, Y. Kuraishi, M. Satoh, Possible involvement of interleukin-1β in neuronal death after transient forebrain ischaemia, Soc. Neurosci. Abst. 18 (1992) 425.5.
115. Mirtella A., Tringali G., Guerriero G., Ghiara P., Parente L., Preziosi P., Navarra P. Evidence that the interleukin-1β-induced prostaglandin E2 release from rat hypothalamus is mediated by type I and type II interleukin-1 receptors. J. Neuroimmunol. 61:1995;171-177.
116. Miura M., Zhu H., Rotello R., Hartwieg E.A., Yuan J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C.elegans cell death gene ced-3. Cell. 75:1993;653-660.
117. Mizel S.B. The interleukins. FASEB J. 3:1989;2379-2388.
118. Molineaux S.M., Casano F.J., Rolando A.M., Peterson E.P., Limjuco G., Chin J., Griffin P.R., Calaycay J.R., Ding G.J.F., Yamin T.-T., Palyha O.C., Luell S., Fletcher D., Miller D.K., Howard A.D., Thornberry N.A., Kotsura M.J. Interleukin-1β (IL-1β) converting enzyme processing in murine macrophages requires a structurally conserved homologue of human IL-1β converting enzyme. Proc. Natl. Acad. Sci. USA. 90:1993;1809-1813.
119. Morioko T., Kalehua A.N., Streit W.J. Characterisation of microglial reaction after middle cerebral artery occlusion in rat brain. J. Comp. Neurol. 327:1993;123-132.
120. Muegge K., Durum S.K. Cytokines and transcription factors. Cytokine. 2:1990;1-8.
121. Muegge K., Vila M., Gusella G.L., Musso T., Herrlich P., Stein B., Durum S.K. Interleukin 1 induction of the c-jun promoter. Proc. Natl. Acad. Sci. USA. 90:1993;7054-7058.
122. Muegge K., Williams T.M., Kant J., Karin M., Chiu R., Schmidt A., Siebenlist U., Young H.A., Durum S.K. Interleukin-1 costimulatary activity on the interleukin-2 promoter via AP-1. Science. 246:1989;249-251.
123. Munday N.A., Vaillancourt J.P., Ali A., Casano F.J., Miller D.K., Molineaux S.M., Yamin T.T., Yu V.L., Nicholson D.W. Molecular cloning and pro-apoptotic activity of ICEre1II and ICEre1III, members of the ICE/CED-3 family of cysteine proteases. J. Biol. Chem. 270:1995;15870-15876.
124. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 297:1980;220-229.
125. Mustafa M.M., Lebel M.H., Ramilo O., Olsen K.D., Reisch J.S., Beutler B., McCracken G.H.J. Correlation of interleukin-1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 115:1989;208-213.
126. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:1996;817-827.
127. Nakamura H., Nakanishi S., Kita A., Kadokawa T. Interleukin-1 induces analgesia in mice by a central action. Eur. J. Pharmacol. 159:1988;49-54.
128. Navarra P., Tsagarakis S., Faria M., Rees L.H., Besser G.M., Grossman A.B. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology. 128:1991;37-44.
129. Nett M.A., Cerretti D.P., Berson N., Seavitt J., Gilbert D.J., Jenkins N.A., Copeland N.G., Black R.A., Chaplin D.D. Molecular cloning of the murine IL-1βconverting enzyme cDNA. J. Immunol. 149:1992;3254-3258.
130. Oppenheim J.J., Kovacs E.J., Matsushima K., Durum S.K. There is more than one interleukin 1. Immmunol. Today. 7:1986;45-46.
131. 2+ in toxic cell killing. TIPS. 10:1989;281-285.
132. Piani D., Constam D.B., Frei K., Fontana A. Macrophages in the brain: friends or enemies. News Physiol. Sci. 9:1994;80-84.
133. Pober J.S., Gimbrone M.J., Lapierre L.A., Mendrick D.L., Fiers W., Rothlein R., Springer T.A. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1986;1893-1896.
134. Quagliarello V.J., Wispelwey B., Long W.J., Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. J. Clin. Invest. 87:1991;1360-1366.
135. Reikerstorfer A., Holz H., Stunnenberg H.G., Busslinger M. Low affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family. J. Biol. Chem. 270:1995;17645-17648.
136. Relton J.K., Martin D., Thompson R.C., Russel D.A. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. 138:1996;206-213.
137. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29:1992;243-246.
138. Rivier C.C., Vale W. In the rat, interleukin-1α acts at the level of the brain and the gonads to interfere with gonadotrophin and sex steroid secretion. Endocrinology. 124:1989;2105-2109.
139. N. Rothwell, S. Loddick, C. Lawrence, Cytokines and neurodegeneration. In: N.J. Rothwell (Ed.), Immune responses in the nervous system, Oxford, 1995, pp. 77-99.
140. Rothwell N.J., Strijbos P.J.L.M. Cytokines in neurodegeneration and repair. Int. J. Devl. Neurosci. 13:1995;179-185.
141. Sapolsky R.M., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 238:1987;522-524.
142. Sharp B.M., Matta S.G., Peterson P.K., Newton R., Chao C., McAllen K. Tumor necrosis factor-α is a potent ACTH secretagogue: comparison with interleukin-1β Endocrinology. 124:1989;3131-3133.
143. Shelton C.A., Wasserman S.A. Pelle encodes a protein kinase required to establish dorsoventral polarity in the drosophila embryo. Cell. 72:1993;515-525.
144. Shiga Y., Onodera H., Kogure K., Yamasaki Y., Yashima Y., Szozuhara H., Sendo F. Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci. Lett. 125:1991;110-112.
145. Sims J.E., Acres R.B., Grubin C. Cloning the interleukin 1 receptor from human T cells. Proc. Natl. Acad. Sci. USA. 86:1989;8946-8950.
146. Sims J., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., Colotta F., Re F., Mantovani A., Shanebeck K., Grabstein K.H., Dower S.K. Interleukin-1 signalling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA. 90:1993;6155-6159.
147. Sims J.E., March C.J., Cosman D., Widmer M.B., MacDonald H.R., McMahan C.J., Grubin C.E., Wignall J.M., Jackson J.L., Call S.M., Gillis S., Dower S.K. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science. 241:1988;585-589.
148. Spranger M., Lindholm D., Bandtlow C., Heumann R., Gnahn H., Näher-Noé M., Thoenn H. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2:1990;69-76.
149. Strieter R.M., Kunkel S.L., Showell H.J., Remick D.G., Phan S.H., Ward P.A., Marks R.M. Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS and IL-1β Science. 243:1989;1467-1469.
150. Sundar T., Cierpial M.A., Kilts C.D., Ritchie J.C. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J. Neurosci. 10:1990;3701-3706.
151. 125I]recombinant human interleukin-1 receptor antagonist. J. Neuroimmunol. 41:1992;51-60.
152. 125I]interleukin-1 binding in brain, endocrine and immune tissues. Brain Res. 623:1993;172-176.
153. Takao T., Tracey D.E., Mitchell W.M., De Souza E.B. Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology. 127:1990;3070-3078.
154. Takeshima R., Kirsch J.R., Koehler R.C., Gomoll A.W., Traystman R.J. Effect of neutrophil monoclonal antibody on infarct volume following transient focal cerebral ischemia in cats. J. Cereb. Blood Flow Metab. 11:1991;s752.
155. Taupin V., Toulmond S., Serrano A., Benavides J., Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. J. Neuroimmunol. 42:1993;177-186.
156. Tewari M., Dixit V.M. Fas- and tumor necrosis factor-induced apoptois is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:1995;3255-3260.
157. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux D.M., Weidner J.R., Aunins J., Schmidt J.A., Tocci M. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 356:1992;768-774.
158. M.H. Thornhill, D.O. Haskard, Leukocyte adhesion to endothelium. In: M.A. Hortton (Ed.), Blood Cell Biochemistry: Macrophages and Related Cells, 5, New York, 1993 pp. 371-392.
159. Tingsborg S., Zetterström M., Alheim K., Hasanvan H., Schultzberg M., Bartfai T. Regionally specific induction of ICE mRNA and enzyme activity in the rat brain and adrenal gland by LPS. Brain Res. 712:1996;153-158.
160. Tobler I., Borbely A.A., Schwyzer M., Fontana A. Interleukin-1 derived from astrocytes enhances slow wave activity in sleep EEG of the rat. Eur. J. Pharmacol. 104:1984;191-192.
161. Toulmond S., Rothwell N. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res. 671:1995;261-266.
162. S. Toulmond, N.J. Rothwell, Time-course of IL-1 receptor antagonist (IL-1ra) expression after brain trauma in the rat, Soc. Neurosci. Abst. 21 (1995) 200.2.
163. Tsagarakis S., Gillies G., Rees L.H., Besser M., Grossman A.B. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinol. 49:1989;98-101.
164. Uehara A., Gottschall P.E., Dahl R.R., Arimura A. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin-releasing factor. Endocrinology. 121:1987;1580-1582.
165. Waage A., Halstensen A., Shalaby R., Brantzaeg P., Keirulf P., Espevik T. Local production of tumour necrosis factor α, interleukin-1 and interleukin-6 in menginococcal meningitis. J. Exp. Med. 170:1989;1859-1867.
166. 2 homodimer. Cell. 78:1994;343-352.
167. Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Ich-1, an ICE/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 78:1994;739-750.
168. Wang S., Miura M., Jung Y.K., Zhu H., Gagliardini V., Shi L., Greenberg A.H., Yuan J. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 271:1996;20580-20587.
169. Wang X., Barone F., Aiyar N.V., Feuerstein G.Z. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke. 28:1997;155-162.
170. Wang X., Yue T.-L., Barone F.C., White R.F., Gagnon R.C., Feurestein G.Z. Concomitant cortical expression of TNF-α and IL-1β mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23:1994;103-114.
171. Wellicome S.M., Thornhill M.H., Pitzalis C., Thomas D.S., Lanchbury J.S.S., Panay G.S., Haskard D.O. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1 or lipopolysaccharide. J. Immunol. 144:1990;2558-2565.
172. Wiessner C., Gehrmann J., Lindholm D., Töpper R., Kreutzberg G.W., Hossman K.A. Expression of transforming growth factor-β1 and interleukin-1β mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol. 86:1993;439-446.
173. Wilson K.P., Black J.-A., Thompson J.A., Kim E.E., Griffith J.P., Navia M.A., Murcko M.A., Chambers S.P., Aldape R.A., Raybuck S.A., Livingstone D.J. Structure and mechanism of IL-1β converting enzyme. Nature. 370:1994;270-275.
174. Wong M.-L., Bongiorno P.B., Gold P.W., Licinio J. Localization of interleukin-1 beta converting enzyme mRNA in rat brain vasculature: evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels. Pathophysiological implications. Neuroimmunomodulation. 2:1995;141-148.
175. Woodroofe M.N., Sarna G.S., Wawda M., Hayes G.M., Loughlin A.J., Tinker A., Curzner M.L. Detection of interleukin-1 and interleukin-6 in adult rat brain following mechanical injury by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Immunol. 33:1991;227-236.
176. Yabuuchi K., Minami M., Katsuata S., Yamasaki A., Satoh A. An in situ hybridisation study of interleukin-1 beta induced by transient forebrain ischemia in the rat brain. Mol. Brain Res. 26:1994;135-142.
177. Yabuuchi K., Minami M., Katsumata S., Satoh M. In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the rat brain. Mol. Brain Res. 20:1993;153-161.
178. Yabuuchi K., Minami M., Katsumata S., Satoh M. Localization of type I interleukin-1 receptor mRNA in the rat brain. Mol. Brain Res. 27:1994;27-36.
179. Yamasaki Y., Matsuo Y., Matsuura N., Onodera H., Itoyama Y., Kogure K. Transient increase of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in ischemic brain areas after focal ischemia in the rat. Stroke. 26:1995;318-323.
180. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischaemic brain damage in rats. Stroke. 26:1995;676-681.
181. Yamasaki Y., Suzuki T., Yamaya H., Matsuura N., Onodera H., Kogure K. Possible involvement of interleukin-1 in ischemic brain edema formation. Neurosci. Lett. 142:1992;45-47.
182. Yan H.Q., Banos M.A., Herregodts P., Hooghe R., Hooghe-Peters E.L. Expression of interleukin (IL)-1, IL-6 and their respective receptors in the normal rat brain and after injury. Eur. J. Immunol. 22:1992;2963-2971.
183. Yanagisawa K., Takagi T., Tsukamoto T., Tetsuka T., Tominaga S. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 318:1993;83-87.
184. Yanagisawa K., Tsukamoto T., Takagi T., Tominaga S. Murine ST2 gene is a member of the primary response gene family induced by growth factors. FEBS Lett. 302:1992;51-53.
185. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:1993;641-652.
186. Zhang R.L., Chopp M., Jiang N., Tang W.X., Prostak J., Manning A.M., Anderson D.C. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke. 26:1995;1438-1442.